APOA1 and female reproductive system neoplasm: In gynecological tumors, it has been reported that APOA1 levels are significantly downregulated in patients with epithelial ovarian cancer serum, and APOA1 is a potential tumor marker for epithelial ovarian cancer [14, 15].